1 / 8

Dengue Vaccine Market To Surpass US$ 1,262.0 Million By 2027

Dengue Vaccines Market Report- 2026 Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.

SANJAYCMI
Download Presentation

Dengue Vaccine Market To Surpass US$ 1,262.0 Million By 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DENGUE VACCINES MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Dengue Vaccines Market - Overview Statistics: The global Dengue Vaccine Market is estimated to account for US$ 1,262.0 Mn in terms of value by the end of 2027. Global Dengue Vaccine Market: Drivers Increasing demand for dengue vaccine is expected to propel growth of the global dengue vaccine market. For instance, the researchers at International Vaccine Institute, South Korea, projected that around 7.8–62.9 million doses of dengue vaccine are required for only routine vaccination of 12–23 mo cohort in first 5 years of the period 2015–2022 with different vaccination schedules. Global Dengue Vaccine Market: Opportunities R&D of vaccines that are effective against all age groups is expected to offer lucrative growth opportunities for players in the global dengue vaccine market. For instance, in November 2019, Takeda Pharmaceutical Company Limited announced that TAK-003, its dengue vaccine candidate demonstrated protection in children ages four to 16 years, regardless of previous dengue exposure. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/dengue- vaccines-market-23 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION Global Dengue Vaccine Market: Restraints Dengue vaccines such as Dengvaxia poses high risk to people without prior dengue infection. This is expected to hinder adoption of dengue vaccines, thereby hindering growth of the market. Key Takeaways: The Government Institutes segment in the global dengue vaccines market was valued at US$ 169.6 Mn in 2019 and is expected to reach US$ 657.6 by 2027 at a CAGR of 18.5% during the forecast period. The growth of the segment is attributed increase in government initiatives to promote awareness and provide vaccination facility to cope up with increasing incidence of dengue in respective countries. Market Trends Major players in the market are focused on developing recombinant subunit vaccines that are effective against dengue. For instance, Merck is assessing the immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue. The study completed phase I stage as of 2019. Dengue vaccine is only recommended in those who have previously had dengue fever. It is given as three injections over a year. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/23 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in January 2019, Takeda Pharmaceutical Company Limited completed acquisition of Shire plc. Global Dengue Vaccine Market: Competitive Landscape Major players operating in the global dengue vaccine market include, Sanofi, Takeda Pharmaceutical Company Limited, GlaxoSmithKline, and Merck & Co. Global Dengue Vaccine Market: Key Developments January 2020: Codagenix, a company developing vaccines and viral therapies for illnesses ranging from the flu and respiratory viruses to dengue fever, raised US$ 20 million in a new round of financing November 2019: Takeda Pharmaceutical Company Limited started a plant to produce dengue vaccine in Germany Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/23 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related